30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: Mazor Robotics

4Q13 revenue: $5.7MM, +111% (U.S. $4.2MM, +200%; ex-U.S. $1.5MM, +15%)

2013 revenue: $20.0MM, +64%

  • Sold 23 systems globally; installed base now 63 (34 in U.S.)
  • 65% of spine cases using Renaissance were multi-level/complex, with 1/3 using a minimally invasive or percutaneous approach
  • Notes that Globus’ robotics acquisition is not a threat, will help to introduce these technologies into spine